448 RESPONSE-GUIDED THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN REDUCES DURATION IN NAIVE AND PEGINTERFERON ALFA-2B/RIBAVIRIN PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV GENOTYPE 1

Saved in:
Bibliographic Details
Title: 448 RESPONSE-GUIDED THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN REDUCES DURATION IN NAIVE AND PEGINTERFERON ALFA-2B/RIBAVIRIN PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV GENOTYPE 1
Authors: Manns, M.P., Poordad, F., Bacon, B.R., Bruno, S., Esteban, R., Silva, M., Buti, M., Burroughs, M., Sniukiene, V., Boparai, N., Brass, C.A., Albrecht, J.K., Bronowicki, J.-P.
Source: Journal of Hepatology. Mar2011 Supplement 1, Vol. 54, pS182-S183. 0p.
Database: Academic Search Ultimate
Description
ISSN:01688278
DOI:10.1016/S0168-8278(11)60450-9